• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR UNKNOWN DRAGONFLY; DIAGNOSTIC INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR UNKNOWN DRAGONFLY; DIAGNOSTIC INTRAVASCULAR CATHETER Back to Search Results
Catalog Number UNK DRAGONFLY
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Hemorrhage/Bleeding (1888); Renal Failure (2041); Tachycardia (2095); Ventricular Fibrillation (2130); Perforation of Vessels (2135); Cardiogenic Shock (2262); Vascular Dissection (3160); Thrombosis/Thrombus (4440)
Event Date 07/01/2019
Event Type  Injury  
Manufacturer Narrative
B3: date of event estimated.D4: the udi number is not known as the catalogue number was not provided.The device was not returned for analysis.A review of the lot history record could not be performed as the device was not returned for evaluation and the lot number was not provided.Additionally, a review of the complaint history could not be completed as the device was not returned and the lot number was not provided.The reported patient effects of dissection, perforation, and thrombus are listed in the dragonfly optis instructions for use as known potential complications which may be encountered during the procedure.In this case, a conclusive cause for the reported patient effect, and the relationship to the product, if any, cannot be determined.A definitive cause for the reported patient effect, and the relationship to the product, if any, cannot be determined.The reported patient effects of renal failure, tachycardia, ventricular fibrillation, cardiogenic shock, hemorrhage/blood loss/bleeding, stroke/cva, thrombosis/thrombus, perforation of vessels, and vascular dissection appear to be related to circumstances of the procedure.There is no indication of a product quality issue with respect to manufacture, design, or labeling.Literature attachment: e-180100article.Literature attachment: appendix e-180100.The additional patient effect of death reported in the article is captured under a separate medwatch report.
 
Event Description
It was reported patients with complex bifurcation lesions had optical coherence tomography (oct)-guided percutaneous coronary intervention (pci) or angiography-guided pci.The primary end point was a composite of major adverse cardiac events (mace), defined as death from a cardiac cause, target-lesion myocardial infarction, or ischemia-driven target-lesion revascularization at a median follow-up of 2 years.The xience everolimus-eluting stent was prespecified for implantation.The article identified xience drug-eluting stents that may be related to stent malposition, patient deaths, myocardial infarction, ischemia, stent thrombosis, target vessel revascularization, re-hospitalization.The article's supplemental appendix mentioned ventricular tachycardia (vt), ventricular fibrillation (vf), cardiogenic shock, major bleeding, stroke, vessel occlusion, perforation, and dissection as procedure related complications; coronary artery bypass graft revascularization was also noted.The supplemental appendix also listed the following procedural related complications during oct guided pci, vt/vf, cardiogenic shock, major bleeding, stroke, vessel occlusion, perforation, dissection and death.Contrast-associated acute kidney injury without an oct/dragonfly malfunction was mentioned during oct guided pci.The article concluded; oct-guided pci had a lower incidence of mace at 2 years than angiography-guided pci.Details are listed in the attached article, titled ¿oct or angiography guidance for pci in complex bifurcation lesions.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNKNOWN DRAGONFLY
Type of Device
DIAGNOSTIC INTRAVASCULAR CATHETER
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT MEDICAL REG#3009600098
4 robbins rd
westford MA 01886
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key17864991
MDR Text Key324848657
Report Number2024168-2023-10796
Device Sequence Number1
Product Code DQO
Combination Product (y/n)N
Reporter Country CodeDA
PMA/PMN Number
K141769 
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Physician
Type of Report Initial
Report Date 10/03/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/03/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK DRAGONFLY
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/11/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Disability; Hospitalization;
Patient Age65 YR
Patient SexMale
-
-